# Breaking the Blister: A Case Report of Bullous Wells’ Syndrome Resolved with Oral Terbinafine

**Authors:** Winnie W Bao, Eunice Y Chow

PMC · DOI: 10.7759/cureus.80060 · Cureus · 2025-03-04

## TL;DR

A rare skin condition called Wells' syndrome was successfully treated with terbinafine after failing multiple other therapies.

## Contribution

This case report presents a novel trigger and effective treatment for bullous Wells' syndrome.

## Key findings

- Oral terbinafine resolved both fungal infection and eosinophilic cellulitis in a patient.
- Tinea pedis and onychomycosis may act as triggers for atypical bullous Wells' syndrome.
- Persistent skin lesions unresponsive to standard treatments should consider Wells' syndrome in the differential diagnosis.

## Abstract

Eosinophilic cellulitis (Wells' syndrome) is a rare inflammatory dermatosis, characterized by erythematous skin lesions, edema, and eosinophilic infiltration into the dermis. While typically affecting the limbs, it is uncommon for the condition to present as bullae on the feet. Most cases are idiopathic; however, triggering factors may include arthropod bites, certain medications, and viral, bacterial, or parasitic infections. In this case, a 52-year-old woman presented with recurrent pruritic, blistering eruptions on her feet over the past year. The lesions were non-responsive to multiple treatments, including topical and oral steroids, several antibiotics, and methotrexate. She was diagnosed with eosinophilic cellulitis by histopathology, possibly triggered by tinea pedis and onychomycosis. A three-month course of oral terbinafine resolved her fungal infection and recurrent eosinophilic cellulitis. This atypical presentation, including persistent scaly patches and bullae resistant to known treatments for eosinophilic cellulitis, highlights the challenges clinicians face when diagnosing this condition among a broad differential. It should be considered for any unexplained recurrent cellulitis-appearing inflammatory skin condition, not responsive to usual therapy. Additional triggers of eosinophilic cellulitis should be considered beyond those already identified in the literature, such as tinea pedis and onychomycosis as presented in this unique case. Addressing the underlying cause may lead to complete remission of eosinophilic cellulitis.

## Linked entities

- **Chemicals:** terbinafine (PubChem CID 1549008)
- **Diseases:** eosinophilic cellulitis (MONDO:0019547), Wells' syndrome (MONDO:0019547), tinea pedis (MONDO:0005984), onychomycosis (MONDO:0001628)

## Full-text entities

- **Diseases:** edema (MESH:D004487), onychomycosis (MESH:D014009), bacterial, or parasitic infections (MESH:D010272), cellulitis (MESH:D002481), erythematous skin lesions (MESH:D012871), Eosinophilic cellulitis (MESH:C536693), tinea pedis (MESH:D014008), fungal infection (MESH:D009181)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11969056/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11969056/full.md

## References

13 references — full list in the complete paper: https://tomesphere.com/paper/PMC11969056/full.md

---
Source: https://tomesphere.com/paper/PMC11969056